Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2017 (2017), Article ID 7012520, 6 pages
https://doi.org/10.1155/2017/7012520
Case Report

Humoral Hypercalcemia of Malignancy with a Parathyroid Hormone-Related Peptide-Secreting Intrahepatic Cholangiocarcinoma Accompanied by a Gastric Cancer

1Department of Endocrinology and Metabolism, Nagoya City West Medical Center, 1-1-1 Hirate-cho, Kita-ku, Nagoya 462-8508, Japan
2Department of Gastroenterology, Nagoya City West Medical Center, 1-1-1 Hirate-cho, Kita-ku, Nagoya 462-8508, Japan
3Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan

Correspondence should be addressed to Katsushi Takeda; pj.dem-tsew@15.adekat.k

Received 1 December 2016; Revised 2 March 2017; Accepted 16 April 2017; Published 10 May 2017

Academic Editor: Michael P. Kane

Copyright © 2017 Katsushi Takeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. F. Stewart, “Hypercalcemia associated with cancer,” The New England Journal of Medicine, vol. 352, no. 4, pp. 373–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. D. Wright, A. I. Tergas, C. V. Ananth et al., “Quality and Outcomes of Treatment of Hypercalcemia of Malignancy,” Cancer Investigation, vol. 33, no. 8, pp. 331–339, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Nakajima, M. Tamai, S. Okaniwa et al., “Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature,” Endocrine Journal, vol. 60, no. 5, pp. 557–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Yamada, H. Shiroeda, S. Shiroeda, K. Sato, T. Arisawa, and M. Tsutsumi, “Cholangiocarcinoma producing parathyroid hormone-related peptide treated with chemoradiation using gemcitabine and S-1,” Internal Medicine, vol. 48, no. 24, pp. 2097–2100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Iino, T. Shimoyama, Y. Akemoto et al., “Humoral hypercalcemia due to gastric carcinoma secreting parathyroid hormone-related protein during chemotherapy: a case report,” Clinical Journal of Gastroenterology, vol. 9, no. 2, pp. 68–72, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. S. H. Ralston, S. J. Gallacher, U. Patel, J. Campbell, and I. T. Boyle, “Cancer-associated hypercalcemia: morbidity and mortality—clinical experience in 126 treated patients,” Annals of Internal Medicine, vol. 112, no. 7, pp. 499–504, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Moseley, M. Kubota, H. Diefenbach-Jagger et al., “Parathyroid hormone-related protein purified from a human lung cancer cell line,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 14, pp. 5048–5052, 1987. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. Suva, G. A. Winslow, R. E. H. Wettenhall et al., “A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression,” Science, vol. 237, no. 4817, pp. 893–896, 1987. View at Publisher · View at Google Scholar · View at Scopus
  9. A. E. Broadus, M. Mangin, K. Ikeda et al., “Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide,” The New England Journal of Medicine, vol. 319, no. 9, pp. 556–563, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. Karaplis, A. Luz, J. Glowacki et al., “Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene,” Genes and Development, vol. 8, no. 3, pp. 277–289, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. C. P. Rodda, M. Kubota, J. A. Heath et al., “Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a similar protein implicated in humoral hypercalcaemia of malignancy,” Journal of Endocrinology, vol. 117, no. 2, pp. 261–271, 1988. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kir and B. M. Spiegelman, “Cachexia and brown fat: a burning issue in cancer,” Trends in Cancer, vol. 2, no. 9, pp. 461–463, 2016. View at Publisher · View at Google Scholar
  13. S. Kir, J. P. White, S. Kleiner et al., “Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia,” Nature, vol. 513, no. 7516, pp. 100–104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. R. Guntur, C. R. Doucette, and C. J. Rosen, “PTHrp comes full circle in cancer biology,” BoneKEy Reports, vol. 4, no. 621, 2015. View at Publisher · View at Google Scholar
  15. M. Kudo, N. Izumi, T. Ichida et al., “Report of the 19th follow-up survey of primary liver cancer in Japan,” Hepatology Research, vol. 46, no. 5, pp. 372–390, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Olnes and R. Erlich, “A review and update on cholangiocarcinoma,” Oncology, vol. 66, no. 3, pp. 167–179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Davis, R. Sadasivan, T. Dwyer, and P. V. Veldhuizen, “Case report: cholangiocarcinoma and hypercalcemia,” The American Journal of the Medical Sciences, vol. 307, no. 5, pp. 350–352, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Lim, J. Han, K. H. Park et al., “Two cases of humoral hypercalcemia of malignancy in metastatic cholangiocarcinoma,” Cancer Research and Treatment, vol. 45, no. 2, pp. 145–149, 2013. View at Publisher · View at Google Scholar · View at Scopus